Are IVIG for chronic unremitting urticaria effective?

Suppr

超能文献

作者信息

Asero R

机构信息

Ambulatorio di Allergologia, Ospedale Caduti Bollatesi, Bollate, MI, Italy.

出版信息

Allergy. 2000 Nov;55(11):1099-101. doi: 10.1034/j.1398-9995.2000.00829.x.

DOI:10.1034/j.1398-9995.2000.00829.x

PMID:11097330

Abstract

摘要

相似文献

Are IVIG for chronic unremitting urticaria effective?

Allergy. 2000 Nov;55(11):1099-101. doi: 10.1034/j.1398-9995.2000.00829.x.

[Treatment of chronic autoimmune urticaria using polyvalent immunoglobulins].

Ann Dermatol Venereol. 1998 Sep;125(9):641-4.

Effect of high-dose intravenous immunoglobulin in delayed pressure urticaria.

Br J Dermatol. 2003 Oct;149(4):836-40. doi: 10.1046/j.1365-2133.2003.05486.x.

Intravenous immunoglobulin in autoimmune chronic urticaria.

Br J Dermatol. 1998 Jan;138(1):101-6. doi: 10.1046/j.1365-2133.1998.02033.x.

Chronic autoimmune urticaria in children.

Acta Dermatovenerol Croat. 2008;16(2):65-71.

Intravenous immunoglobulin in urticaria.

J Investig Allergol Clin Immunol. 2013;23(1):71-3.

Plasmapheresis for severe, unremitting, chronic urticaria.

Lancet. 1992 May 2;339(8801):1078-80. doi: 10.1016/0140-6736(92)90666-q.

Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence.

J Dermatolog Treat. 2018 Feb;29(1):80-97. doi: 10.1080/09546634.2017.1329505. Epub 2017 May 31.

The effectiveness of low-dose intravenous immunoglobulin in chronic urticaria.

Acta Derm Venereol. 2000 May;80(3):225. doi: 10.1080/000155500750043131.

Intravenous immunoglobulin as a potential therapy for refractory urticaria - a review.

Inflamm Allergy Drug Targets. 2012 Oct;11(5):375-81. doi: 10.2174/187152812803251024.

引用本文的文献

Treatment of Refractory Chronic Urticaria.

Indian J Dermatol. 2015 May-Jun;60(3):230-7. doi: 10.4103/0019-5154.156325.

Role of biologics in intractable urticaria.

Biologics. 2015 Apr 13;9:25-33. doi: 10.2147/BTT.S63839. eCollection 2015.

Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

World Allergy Organ J. 2012 Nov;5(11):125-47. doi: 10.1097/WOX.0b013e3182758d6c.

An approach to the patient with urticaria.

Clin Exp Immunol. 2008 Aug;153(2):151-61. doi: 10.1111/j.1365-2249.2008.03693.x.

Clinical uses of intravenous immunoglobulin.

Clin Exp Immunol. 2005 Oct;142(1):1-11. doi: 10.1111/j.1365-2249.2005.02834.x.

Chronic urticaria: aetiology, management and current and future treatment options.

Drugs. 2004;64(22):2515-36. doi: 10.2165/00003495-200464220-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Are IVIG for chronic unremitting urticaria effective?

Allergy. 2000 Nov;55(11):1099-101. doi: 10.1034/j.1398-9995.2000.00829.x.

[Treatment of chronic autoimmune urticaria using polyvalent immunoglobulins].

Ann Dermatol Venereol. 1998 Sep;125(9):641-4.

Effect of high-dose intravenous immunoglobulin in delayed pressure urticaria.

Br J Dermatol. 2003 Oct;149(4):836-40. doi: 10.1046/j.1365-2133.2003.05486.x.

Intravenous immunoglobulin in autoimmune chronic urticaria.

Br J Dermatol. 1998 Jan;138(1):101-6. doi: 10.1046/j.1365-2133.1998.02033.x.

Chronic autoimmune urticaria in children.

Acta Dermatovenerol Croat. 2008;16(2):65-71.

Intravenous immunoglobulin in urticaria.

J Investig Allergol Clin Immunol. 2013;23(1):71-3.

Plasmapheresis for severe, unremitting, chronic urticaria.

Lancet. 1992 May 2;339(8801):1078-80. doi: 10.1016/0140-6736(92)90666-q.

Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence.

J Dermatolog Treat. 2018 Feb;29(1):80-97. doi: 10.1080/09546634.2017.1329505. Epub 2017 May 31.

The effectiveness of low-dose intravenous immunoglobulin in chronic urticaria.

Acta Derm Venereol. 2000 May;80(3):225. doi: 10.1080/000155500750043131.

Intravenous immunoglobulin as a potential therapy for refractory urticaria - a review.

Inflamm Allergy Drug Targets. 2012 Oct;11(5):375-81. doi: 10.2174/187152812803251024.

引用本文的文献

Treatment of Refractory Chronic Urticaria.

Indian J Dermatol. 2015 May-Jun;60(3):230-7. doi: 10.4103/0019-5154.156325.

Role of biologics in intractable urticaria.

Biologics. 2015 Apr 13;9:25-33. doi: 10.2147/BTT.S63839. eCollection 2015.

Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

World Allergy Organ J. 2012 Nov;5(11):125-47. doi: 10.1097/WOX.0b013e3182758d6c.

An approach to the patient with urticaria.

Clin Exp Immunol. 2008 Aug;153(2):151-61. doi: 10.1111/j.1365-2249.2008.03693.x.

Clinical uses of intravenous immunoglobulin.

Clin Exp Immunol. 2005 Oct;142(1):1-11. doi: 10.1111/j.1365-2249.2005.02834.x.

Chronic urticaria: aetiology, management and current and future treatment options.

Drugs. 2004;64(22):2515-36. doi: 10.2165/00003495-200464220-00003.